Integral Ad Science’s (IAS) “Hold” Rating Reiterated at Benchmark

Benchmark reissued their hold rating on shares of Integral Ad Science (NASDAQ:IAS) in a research note issued to investors on Monday morning, Benzinga reports.

Several other equities analysts also recently commented on the stock. Loop Capital began coverage on shares of Integral Ad Science in a report on Tuesday, April 30th. They set a buy rating and a $15.00 price target on the stock. Morgan Stanley upped their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an equal weight rating in a report on Tuesday, July 23rd. Barclays cut their price target on shares of Integral Ad Science from $16.00 to $12.00 and set an equal weight rating on the stock in a report on Monday, April 15th. Raymond James upped their target price on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an outperform rating in a research note on Friday. Finally, Craig Hallum dropped their target price on shares of Integral Ad Science from $20.00 to $18.00 and set a buy rating on the stock in a research note on Friday, May 10th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of $16.58.

Integral Ad Science Price Performance

Shares of NASDAQ IAS traded down $0.27 during mid-day trading on Monday, hitting $10.71. 1,180,607 shares of the company’s stock traded hands, compared to its average volume of 1,697,608. The company’s 50-day moving average is $9.85 and its two-hundred day moving average is $10.94. The company has a debt-to-equity ratio of 0.13, a current ratio of 4.32 and a quick ratio of 4.32. The company has a market capitalization of $1.72 billion, a P/E ratio of 1,098.00, a PEG ratio of 1.47 and a beta of 1.54. Integral Ad Science has a 1 year low of $7.98 and a 1 year high of $17.53.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Thursday, August 1st. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $129.01 million for the quarter, compared to analysts’ expectations of $126.31 million. Integral Ad Science had a net margin of 0.57% and a return on equity of 0.32%. The business’s revenue was up 13.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.05 EPS. On average, equities analysts anticipate that Integral Ad Science will post 0.22 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CAO Alexis Gil II sold 2,792 shares of the company’s stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total value of $25,379.28. Following the sale, the chief accounting officer now owns 145,550 shares in the company, valued at $1,323,049.50. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Integral Ad Science news, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $9.09, for a total transaction of $25,379.28. Following the completion of the transaction, the chief accounting officer now owns 145,550 shares in the company, valued at approximately $1,323,049.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Lisa Utzschneider sold 6,445 shares of the business’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $9.68, for a total value of $62,387.60. Following the completion of the transaction, the chief executive officer now directly owns 214,563 shares of the company’s stock, valued at $2,076,969.84. The disclosure for this sale can be found here. In the last 90 days, insiders sold 14,434 shares of company stock valued at $138,112. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Integral Ad Science

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. grew its holdings in shares of Integral Ad Science by 605.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock worth $39,429,000 after buying an additional 2,351,414 shares in the last quarter. abrdn plc purchased a new stake in shares of Integral Ad Science in the fourth quarter valued at about $25,285,000. Vanguard Group Inc. grew its holdings in shares of Integral Ad Science by 10.7% in the fourth quarter. Vanguard Group Inc. now owns 8,106,247 shares of the company’s stock valued at $116,649,000 after purchasing an additional 780,469 shares during the period. P2 Capital Partners LLC purchased a new stake in shares of Integral Ad Science in the fourth quarter valued at about $11,144,000. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Integral Ad Science by 449,805.3% in the second quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock valued at $4,154,000 after purchasing an additional 427,315 shares during the period. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.